Clinical Trial Update: A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction [Phase 3]

View source ↗

Summary

A six-month Phase 3 randomized controlled trial evaluating Probuphine for opioid dependency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Probuphine (buprenorphine implant)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Opioid Dependency | Phase 3 | Status: COMPLETED